Detalhe da pesquisa
1.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
; 141(6): 609-619, 2023 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36351239
2.
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Blood
; 139(14): 2173-2185, 2022 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34871373
3.
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(9): e29123, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34061452
4.
Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment.
Pediatr Blood Cancer
; 68(9): e28315, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32391940
5.
Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients.
Pediatr Blood Cancer
; 67(3): e28092, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31793170
6.
Analysis of semen parameters in a young cohort of cancer patients.
Pediatr Blood Cancer
; 64(2): 381-386, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27621105
7.
Parent-perceived Facilitators in the Transition of Care for Young Adult Survivors of Childhood Cancer.
J Pediatr Hematol Oncol
; 39(7): e377-e380, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28085750
8.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv
; 8(9): 2182-2192, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38386999
9.
Patient-perceived facilitators in the transition of care for young adult survivors of childhood cancer.
Pediatr Blood Cancer
; 60(8): 1365-8, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23441065
10.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35482927
11.
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy.
Blood Cancer Discov
; 3(2): 90-94, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35015687
12.
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
J Clin Oncol
; 40(9): 932-944, 2022 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34767461
13.
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19.
Clin Cancer Res
; 28(17): 3804-3813, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35705524
14.
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.
Lancet Haematol
; 8(10): e711-e722, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34560014
15.
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
J Clin Oncol
; 39(8): 920-930, 2021 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33417474
16.
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol
; 39(27): 3044-3055, 2021 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34156874
17.
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children.
Blood Adv
; 4(20): 5174-5183, 2020 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33095872
18.
Chimeric Antigen Receptor T-Cell Therapy Clinical Results in Pediatric and Young Adult B-ALL.
Hemasphere
; 3(4): e279, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31723849
19.
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Blood Adv
; 3(22): 3539-3549, 2019 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31738832
20.
Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232.
Cancer Med
; 7(1): 3-12, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29274118